Exclusive

Publication

Byline

Location

International Clinical Trial: Effect of an Exercise Program on Metabolic Syndrome in Endometrial Cancer Patients after Oophorectom

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (KCT0011862) titled 'Effect of an Exercise Program on Metabolic Syndrome in Endometrial Cancer Pati... Read More


International Clinical Trial: Effect of prophylactic ondansetron on hemodynamic changes in elderly patients following spinal anesthesia: A Randomized Controlled Trial

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (TCTR20260416008) titled 'Effect of prophylactic ondansetron on hemodynamic changes in elderly pati... Read More


International Clinical Trial: Community-Based Interventions to Increase Diabetic Retinopathy Screening Uptake: A Cluster-Based Implementation Study in Thailand

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (TCTR20260416004) titled 'Community-Based Interventions to Increase Diabetic Retinopathy Screening ... Read More


International Clinical Trial: Effects of Exercise Snacks on Cardiorespiratory Fitness, Quality of Life, and Well-Being, and Cardiometabolic Health in Inactive Adults

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (TCTR20260416009) titled 'Effects of Exercise Snacks on Cardiorespiratory Fitness, Quality of Life,... Read More


International Clinical Trial: A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment, and two-sequence of Dapagliflozin tablets 10 mg, relative to Forxiga tablets 10 mg in healthy Thai participants under fasting condition

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (TCTR20260416005) titled 'A Bioequivalence study of a randomized, open-label, single dose, two-way ... Read More


International Clinical Trial: Effect of intravenous hydrocortisone in in-hospital acquire sepsis: a randomized control trial

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (TCTR20260416001) titled 'Effect of intravenous hydrocortisone in in-hospital acquire sepsis: a ran... Read More


International Clinical Trial: Investigating the Effects of Visual Stimuli from Horticultural Plants on Brain Activation and Functional Connectivity

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (KCT0011861) titled 'Investigating the Effects of Visual Stimuli from Horticultural Plants on Brain... Read More


Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, April 15 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More


Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, April 15 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More


Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, April 15 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More